Ellingson M, Weinberger D, van der Linden M, Perniciaro S
J Infect Dis. 2023; 229(6):1669-1673.
PMID: 38059558
PMC: 11175678.
DOI: 10.1093/infdis/jiad538.
Horn M, Theilacker C, Sprenger R, von Eiff C, Mahar E, Schiffner-Rohe J
PLoS One. 2023; 18(2):e0281261.
PMID: 36791091
PMC: 9931105.
DOI: 10.1371/journal.pone.0281261.
Perniciaro S, van der Linden M
Lancet Reg Health Eur. 2021; 7:100126.
PMID: 34557837
PMC: 8454757.
DOI: 10.1016/j.lanepe.2021.100126.
Li M, Wang Y, Zhang H, Liu Y, Chen X, Yang H
Hum Vaccin Immunother. 2020; 17(1):146-156.
PMID: 32530720
PMC: 7872053.
DOI: 10.1080/21645515.2020.1757996.
van der Linden M, Imohl M, Perniciaro S
PLoS One. 2019; 14(8):e0220453.
PMID: 31369597
PMC: 6675109.
DOI: 10.1371/journal.pone.0220453.
Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults.
Marra F, Vadlamudi N
Aging Dis. 2019; 10(2):404-418.
PMID: 31011485
PMC: 6457056.
DOI: 10.14336/AD.2018.0512.
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
Hanquet G, Krizova P, Valentiner-Branth P, Ladhani S, Nuorti J, Lepoutre A
Thorax. 2018; 74(5):473-482.
PMID: 30355641
PMC: 6484683.
DOI: 10.1136/thoraxjnl-2018-211767.
Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
Kuchenbecker U, Chase D, Reichert A, Schiffner-Rohe J, Atwood M
PLoS One. 2018; 13(5):e0197905.
PMID: 29795647
PMC: 5967715.
DOI: 10.1371/journal.pone.0197905.
Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis.
Heo J, Seo Y, Choi W, Lee J, Yoon J, Lee S
PLoS One. 2018; 13(3):e0194598.
PMID: 29596444
PMC: 5875769.
DOI: 10.1371/journal.pone.0194598.
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.
Kuhlmann A, von der Schulenburg J
Eur J Health Econ. 2016; 18(3):273-292.
PMID: 26905404
DOI: 10.1007/s10198-016-0770-9.
Population-based epidemiology and microbiology of community-onset bloodstream infections.
Laupland K, Church D
Clin Microbiol Rev. 2014; 27(4):647-64.
PMID: 25278570
PMC: 4187633.
DOI: 10.1128/CMR.00002-14.
[Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany].
Fatkenheuer G, Kwetkat A, Pletz M, Schelling J, Schulz R, van der Linden M
Z Gerontol Geriatr. 2014; 47(4):302-9.
PMID: 24850498
DOI: 10.1007/s00391-014-0650-9.
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.
van de Vooren K, Duranti S, Curto A, Garattini L
Pharmacoeconomics. 2013; 32(1):29-45.
PMID: 24288207
DOI: 10.1007/s40273-013-0113-y.
Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.
Grzesiowski P, Aguiar-Ibanez R, Kobryn A, Durand L, Puig P
Hum Vaccin Immunother. 2012; 8(10):1382-94.
PMID: 23095867
PMC: 3660757.
DOI: 10.4161/hv.21571.
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany.
Kuhlmann A, Theidel U, Pletz M, von der Schulenburg J
Health Econ Rev. 2012; 2(1):4.
PMID: 22828176
PMC: 3463422.
DOI: 10.1186/2191-1991-2-4.
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).
Imohl M, Reinert R, van der Linden M
Int J Microbiol. 2010; 2010:874189.
PMID: 20671944
PMC: 2910462.
DOI: 10.1155/2010/874189.
The Viriato study: update on antimicrobial resistance of microbial pathogens responsible for community-acquired respiratory tract infections in Portugal.
Melo-Cristino J, Santos L, Silva-Costa C, Friaes A, Pinho M, Ramirez M
Paediatr Drugs. 2010; 12 Suppl 1:11-7.
PMID: 20590169
DOI: 10.2165/11538730-S0-000000000-00003.
Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany.
van der Linden M, Reinert R
Eur J Clin Microbiol Infect Dis. 2010; 29(7):749-54.
PMID: 20432051
DOI: 10.1007/s10096-010-0945-8.
Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.
Imohl M, Reinert R, Ocklenburg C, van der Linden M
J Clin Microbiol. 2010; 48(4):1291-6.
PMID: 20107087
PMC: 2849605.
DOI: 10.1128/JCM.01937-09.
Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.
Fenoll A, Granizo J, Aguilar L, Gimenez M, Aragoneses-Fenoll L, Hanquet G
J Clin Microbiol. 2009; 47(4):1012-20.
PMID: 19225097
PMC: 2668361.
DOI: 10.1128/JCM.01454-08.